Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 700 of 1863 entries
View as:

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005638 Org: User:
Start: 10/31/99 End: 04/30/04 Due: 04/30/05

Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis Methods

Phase: N/A Priority: Normal
NCT ID: NCT02091518 Org: User:
Start: 03/31/14 End: 09/30/25 Due: 09/30/26

Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005630 Org: User:
Start: 07/31/99 End: 05/31/02 Due: 05/31/03

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06123338 Org: User:
Start: 02/01/24 End: 11/30/27 Due: 11/30/28

Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT03319537 Org: User:
Start: 10/05/17 End: 06/05/23 Due: 06/05/24

Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00142506 Org: User:
Start: 02/28/05 End: 04/30/14 Due: 04/30/15

BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT01894672 Org: User:
Start: 07/31/13 End: 03/17/16 Due: 03/17/17

A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05566574 Org: User:
Start: 09/30/22 End: 09/30/25 Due: 09/30/26

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00398138 Org: User:
Start: 10/31/06 End: 06/30/09 Due: 06/30/10

Chemotherapy in Treating Patients With Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00002675 Org: User:
Start: 05/31/95 End: 01/31/01 Due: 01/31/02

Women Surviving Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00596349 Org: User:
Start: 11/30/04 End: 02/28/09 Due: 02/28/10

Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01919086 Org: User:
Start: 08/06/13 End: 05/16/24 Due: 05/16/25

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

Phase: N/A Priority: Normal
NCT ID: NCT00503646 Org: User:
Start: 05/31/07 End: - Due: -

Family Access to Care Study (FACS)

Phase: N/A Priority: Normal
NCT ID: NCT00582218 Org: User:
Start: 02/28/03 End: 02/29/08 Due: 02/28/09

Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00003541 Org: User:
Start: 06/30/98 End: 07/31/06 Due: 07/31/07

Differential Risks for Melanoma: p16 and DNA Repair

Phase: N/A Priority: Normal
NCT ID: NCT00615095 Org: User:
Start: 02/28/97 End: 04/30/11 Due: 04/30/12

3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT01751451 Org: User:
Start: 12/18/12 End: 09/28/20 Due: 09/28/21

Understanding the Late Effects of Surviving a Pediatric Brain Tumor

Phase: N/A Priority: Normal
NCT ID: NCT03208387 Org: User:
Start: 06/28/17 End: 06/30/25 Due: 06/30/26

Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)

Phase: N/A Priority: Normal
NCT ID: NCT00581958 Org: User:
Start: 11/30/07 End: 10/31/18 Due: 10/31/19

Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00620633 Org: User:
Start: 02/08/08 End: 02/26/21 Due: 02/26/22

Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02642913 Org: User:
Start: 12/31/15 End: 03/01/21 Due: 03/01/22

Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA

Phase: N/A Priority: Normal
NCT ID: NCT00588289 Org: User:
Start: 09/30/99 End: 10/31/13 Due: 10/31/14

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005599 Org: User:
Start: 02/29/00 End: 08/31/04 Due: 08/31/05

An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues

Phase: N/A Priority: Normal
NCT ID: NCT05540392 Org: User:
Start: 09/09/22 End: 09/30/25 Due: 09/30/26

A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05793593 Org: User:
Start: 03/17/23 End: 03/31/26 Due: 03/31/27